# EDGAR Filing Document

**Accession Number:** 0001837678
**File Stem:** 0001628280-26-019554
**Filing Date:** 2026-3
**Character Count:** 8075
**Document Hash:** 4e0cfbc7c0e6ee3a1bcf3a2673a30e62
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-019554.hdr.sgml**: 20260318

**ACCESSION NUMBER**: 0001628280-26-019554

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260316

**FILED AS OF DATE**: 20260318

**DATE AS OF CHANGE**: 20260318

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Orszag Peter Richard
- **CENTRAL INDEX KEY:** 0001837678

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-32492
- **FILM NUMBER:** 26770941

**MAIL ADDRESS:**
- **STREET 1:** 30 ROCKEFELLER PLAZA
- **STREET 2:** LAZARD
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10112
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lazard, Inc.
- **CENTRAL INDEX KEY:** 0001311370
- **STANDARD INDUSTRIAL CLASSIFICATION:** INVESTMENT ADVICE [6282]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 980437848
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 30 ROCKEFELLER PLAZA
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10112
- **BUSINESS PHONE:** (212) 632-6000

**MAIL ADDRESS:**
- **STREET 1:** 30 ROCKEFELLER PLAZA
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10112

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Lazard Ltd
- **DATE OF NAME CHANGE:** 20041213

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Orszag Peter Richard<br><sub>(Last) (First) (Middle)</sub><br>C/O LAZARD, INC.<br>30 ROCKEFELLER PLAZA<br><sub>(Street)</sub><br>NEW YORK, NY 10112<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-03-16 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_CEO & Chairman_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Lazard, Inc. [ LAZ ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-03-16 |  | M |  | 138340 | A | <sup>(1)</sup> | 321614 | D |  |
| Common Stock | 2026-03-16 |  | D |  | 41502<sup>(2)</sup> | D | 40.82<sup>(3)</sup> | 280112 | D |  |
| Common Stock | 2026-03-17 |  | S |  | 67170<sup>(4)</sup> | D | 40.7318<sup>(5)</sup> | 212942 | D |  |
| Common Stock | 2026-03-17 |  | S |  | 2000<sup>(4)</sup> | D | 41.6593<sup>(6)</sup> | 210942 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Participation Units<sup>(7)</sup> | <sup>(8)</sup> | 2026-03-16 |  | M |  |  | 138340 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 138340 | <sup>(8)</sup> | 168206 | D |  |

---

### Footnotes:

(1) Shares of Common Stock were acquired upon the exchange of the Restricted Participation Units ("RPUs") referenced in Footnote (7).

(2) Represents shares of Common Stock sold to the Company to cover estimated taxes arising from the exchange of RPUs referenced in Footnote (7).

(3) Represents the average of the high and low price of Common Stock on the New York Stock Exchange on the date of the exchange of the RPUs referenced in Footnote (7).

(4) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. Sales of shares pursuant to the plan are intended to cover estimated taxes and other personal expenditures.

(5) The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 17, 2026 in trades with average execution prices ranging from $40.45 to $41.44 inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.

(6) The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 17, 2026 in trades with average execution prices ranging from $41.45 to $42.00 inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.

(7) Represents a prior grant of RPUs awarded with respect to compensation for 2022 for which service and other conditions have been satisfied.

(8) Each PRU represents an interest in Lazard Group LLC that may be exchanged for one share of Common Stock.

**Signature:** /s/ Peter R. Orszag by Shari L. Soloway under a P of A  
**Date:** 2026-03-18

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**